Table 2.
Intervention | FEV1 | PaO2 | PaCO2 | Effective rate | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
No. of studies | I/C | MD,95% CI | NO. of studies | I/C | MD,95% CI | NO. of studies | I/C | MD,95% CI | NO. of studies | I/C | OR,95% CI | |
WJ + RP vs RP | 6 | 212/202 | 0.25[0.19,0.30] | 8 | 270/260 | 9.90[5.02,14.78] | 8 | 270/260 | −5.40[− 8.33,-2.46] | 10 | 344/322 | 3.60[2.32,5.59] |
SBP + RP vs RP | 2 | 79/80 | 0.40[−0.63,1.43] | 5 | 154/154 | 4.24[1.10,7.38] | 5 | 154/154 | −5.33[−9.68,-0.99] | 11 | 426/423 | 3.56[2.02,6.29] |
YBBX + RP vs RP | 0 | NA | NA | 0 | NA | NA | 0 | NA | NA | 2 | 88/88 | 2.26[0.85,5.99] |
DC + RP vs RP | 4 | 136/130 | 0.05[− 0.04,0.15] | 1 | 42/40 | 5.20[−0.15.10.55] | 1 | 42/40 | −7.40[−12.17,-2.63] | 6 | 211/205 | 3.63[1.91,6.89] |
QQHT + RP vs RP | 3 | 166/166 | 0.34[0.10,0.58] | 3 | 92/92 | 11.74[4.21,19.27] | 3 | 92/92 | −7.65[−9.34,-5.95] | 7 | 222/222 | 4.29[2.18,8.46] |
MXSG + RP vs RP | 3 | 131/129 | 0.38[−0.05,0.80] | 3 | 130/130 | 6.66[−0.55,13.86] | 2 | 80/80 | −8.80[−10.21,-7.38] | 13 | 683/669 | 2.77[1.86,4.11] |
I/C: Sample size of intervention/control groups. MD Mean Difference, CI Confidence interval, OR Odds Ratio